Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier.

Faist A; Schloer S; Mecate-Zambrano A; Janowski J; Schreiber A; Boergeling Y; Conrad BCG; Kumar S; Toebben L; Schughart K; Baumgardt M; Kessler M; Hoenzke K; Hocke A; Trautmann M; Kato H; Hartmann W; Christersson A; Rescher U; Mellmann A; Kuehn J; Kuempers P; Wolff T; Wiewrodt R; Rovas A; Barth P; Wiebe K; Brunotte L; Ludwig S (2023)
In: Antiviral Research, 209
Type of Publication: Research article (journal)

High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma

Schulze AB, Kuntze A, Schmidt LH, Mohr M, Marra A, Hillejan L, Schulz C, Görlich D, Hartmann W, Bleckmann A, Evers G (2022)
In: Cancers, 14(6)
Type of Publication: Research article (journal)

Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition

Kemper M; Evers G; Schulze AB; Sperveslage J; Schülke C; Lenz G; Herold T; Hartmann W; Schildhaus HU; Bleckmann A (2022)
In: Oncotarget, 13
Type of Publication: Research article (journal)

563P First-in-class CD13-targeted tissue factor tTF-NGR in patients with recurrent or refractory malignant tumours: Safety and pharmacokinetic results of a phase I study

Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Kessler T, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Schmidt H, Lenz G. Mesters R, Berdel WE (2020)
In: (eds.), ..
Type of Publication: Research article in edited proceedings (conference)

Requirement for YAP1 signaling in myxoid liposarcoma

Trautmann M, Cheng Y, Jensen P, Azoitei N, Brunner I, Hüllein J, Slabicki M, Isfort I, Cyra M, Berthold R, Wardelmann E, Huss S, Altvater B, Rossig C, Hafner S, Simmet T, Ståhlberg A, Åman P, Zenz T, Lange U, Kindler T, Scholl C, Hartmann W, Fröhling S (2019)
In: EMBO Molecular Medicine, 2019
Type of Publication: Research article (journal)

Publications

Contact

Top-Links

Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier. Faist A; Schloer S; Mecate-Zambrano A; Janowski J; Schreiber A; Boergeling Y; Conrad BCG; Kumar S; Toebben L; Schughart K; Baumgardt M; Kessler M; Hoenzke K; Hocke A; Trautmann M; Kato H; Hartmann W; Christersson A; Rescher U; Mellmann A; Kuehn J; Kuempers P; Wolff T; Wiewrodt R; Rovas A; Barth P; Wiebe K; Brunotte L; Ludwig S (2023) In: Antiviral Research, 209 Type of Publication: Research article (journal)
High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts Schulze, Arik Bernard; Wenge, Daniela Vanessa; Evers, Georg; Heitkötter, Birthe Franziska; Bleckmann, Annalen; Schmidt, Lars Henning; Mohr, Michael; Hartmann, Wolfgang; Arteaga, Maria Francisca; Mikesch, Jan-Henrik (2023) In: Translational lung cancer research, 12(4) Type of Publication: Research article (journal)
High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma Schulze AB, Kuntze A, Schmidt LH, Mohr M, Marra A, Hillejan L, Schulz C, Görlich D, Hartmann W, Bleckmann A, Evers G (2022) In: Cancers, 14(6) Type of Publication: Research article (journal)
Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma Fuest, Sebastian; Post, Christoph; Balbach, Sebastian T.; Jabar, Susanne; Neumann, Ilka; Schimmelpfennig, Sandra; Sargin, Sarah; Nass, Elke; Budde, Thomas; Kailayangiri, Sareetha; Altvater, Bianca; Ranft, Andreas; Hartmann, Wolfgang; Dirksen, Uta; Rossig, Claudia; Schwab, Albrecht; Pethő, Zoltán (2022) In: Cancers, 14(19) Type of Publication: Research article (journal)
Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition Kemper M; Evers G; Schulze AB; Sperveslage J; Schülke C; Lenz G; Herold T; Hartmann W; Schildhaus HU; Bleckmann A (2022) In: Oncotarget, 13 Type of Publication: Research article (journal)
Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition Kemper M, Evers G, Schulze AB, Sperveslage J, Schülke C, Lenz G, Herold T, Hartmann W, Schildhaus HU, Bleckmann A (2021) In: Oncotarget, 12(19) Type of Publication: Research article (journal)
563P First-in-class CD13-targeted tissue factor tTF-NGR in patients with recurrent or refractory malignant tumours: Safety and pharmacokinetic results of a phase I study Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Kessler T, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Schmidt H, Lenz G. Mesters R, Berdel WE (2020) In: (eds.), .. Type of Publication: Research article in edited proceedings (conference)
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Stalmann U, Berning B, Kratz-Albers K, Middelberg-Bisping K, Wiebe S, Albring J, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Bormann E, Schmidt H, Lenz G, Kessler T, Mesters RM, Berdel WE (2020) In: Cancers, 12(6) Type of Publication: Research article (journal)
Requirement for YAP1 signaling in myxoid liposarcoma Trautmann M, Cheng Y, Jensen P, Azoitei N, Brunner I, Hüllein J, Slabicki M, Isfort I, Cyra M, Berthold R, Wardelmann E, Huss S, Altvater B, Rossig C, Hafner S, Simmet T, Ståhlberg A, Åman P, Zenz T, Lange U, Kindler T, Scholl C, Hartmann W, Fröhling S (2019) In: EMBO Molecular Medicine, 2019 Type of Publication: Research article (journal)
SS18-SSX-dependent YAP/TAZ Signaling in Synovial Sarcoma Isfort I, Cyra M, Elges S, Kailayangiri S, Altvater B, Rossig C, Steinestel K, Grünewald I, Huss S, Eßeling E (2019) In: Clinical Cancer Research, 2019 Type of Publication: Research article (journal)